NCT04205825

Brief Summary

The hypothesis is that patients undergoing cardiac catheterization, in which the New Safety Checklist has been used, have fewer perioperative complications compared to patients in which the habitual practice has been used.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
6,000

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 2, 2019

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

December 12, 2019

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 20, 2019

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
Last Updated

December 20, 2019

Status Verified

December 1, 2019

Enrollment Period

1 year

First QC Date

December 12, 2019

Last Update Submit

December 17, 2019

Conditions

Keywords

NursingPatient SafetyChecklistCardiology

Outcome Measures

Primary Outcomes (1)

  • INCIDENCE of PERIOPERATIVE COMPLICATIONS

    The perioperative complications will be collected after randomization, from discharge or up to24 hours post-procedure. The clinical history will be reviewed to evaluate the incidence of complications. Expected complications will be: severe systemic complications (major cardiovascular events \[MACE\], coronary artery complications, and structural complications), peripheral vascular complications, and reactions to contrast media.

    from the discharge or up to 24 hours post-procedure

Secondary Outcomes (3)

  • Socio-demographic data

    from the discharge or up to 24 hours post-procedure

  • Clinical data

    from the discharge or up to 24 hours post-procedure

  • Procedure data

    from the discharge or up to 24 hours post-procedure

Study Arms (2)

New Safety Checklist

EXPERIMENTAL

Patients randomized in the New Safety Checklist intervention, nurses will use the New Safety Checklist, which we have named: INCARDIO-PASS (Interventional CARDIOlogy-Patient Safety System) checklist.

Other: The New Safety Checklist

Habitual Practice

NO INTERVENTION

Patients randomized in this arm they will receive the habitual practice.

Interventions

Patients randomized in the New Safety Checklist intervention, nurses will use the New Safety Checklist, which we have named: INCARDIO-PASS (Interventional CARDIOlogy-Patient Safety System) checklist.

New Safety Checklist

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients (\>18 years) undergoing cardiological intervention in hemodynamic units and interventionist cardiology.
  • Patients who accept to participate in the study.

You may not qualify if:

  • Patients undergoing urgent procedure.
  • Patients requiring ventilatory support or in a situation of hemodynamic instability.
  • Patients with cognitive impairment, mental disability or other serious difficulty in communication.
  • Patients with insufficient fluidity of the main languages.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

FGS Hospital de la Santa Creu i Sant Pau

Barcelona, 08041, Spain

RECRUITING

Central Study Contacts

Adrian Marquez Lopez, RN. MsC. PhD student.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 12, 2019

First Posted

December 20, 2019

Study Start

December 2, 2019

Primary Completion

December 1, 2020

Study Completion

December 1, 2020

Last Updated

December 20, 2019

Record last verified: 2019-12

Locations